BluePath Capital Management
AMGN icon

BluePath Capital Management’s Amgen AMGN Stock Holding History

BluePath Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.61M Buy
6,192
+2,595
+72% +$1.03M 1.36% 12
2026
Q2 		$1.3M Buy
3,597
+308
+9% +$105K 0.71% 44
2026
Q1 		$1.16M Buy
+3,289
New +$1.17M 0.8% 41

Other funds holding AMGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Forum Financial Management
Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

BluePath Capital Management's AMGN Position: Q3 2026 in Review

BluePath Capital Management increased its Amgen (AMGN) stake by 72% in Q3 2026, buying an estimated $1.03M and bringing the position to 6,192 shares worth $2.61M. The position accounts for 1.36% of the portfolio, ranked #12.

BluePath Capital Management first reported a position in AMGN in Q1 2026 and has held it in 3 quarters since. 1,196 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • BluePath Capital Management held 6,192 shares of Amgen worth $2.61M as of Q3 2026.
  • BluePath Capital Management bought 2,595 Amgen shares in Q3 2026, an estimated $1.03M.
  • Amgen made up 1.36% of BluePath Capital Management's portfolio in Q3 2026, its #12 holding.
  • BluePath Capital Management first reported a position in Amgen in Q1 2026 and has held it in 3 quarters since.
  • 1,196 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.